On 25 September 2018, the President of the Eurasian Patent Office (EAPO) and the Acting Commissioner of the Korean Intellectual Property Office (KIPO) signed a Patent Prosecution Highway (PPH) Memorandum of Understanding.
The pilot PPH-Mottainai and PCT-PPH bilateral programs between the EAPO and KIPO have started on 1 January 2019, enabling work-sharing and accelerated treatment of patent applications at both offices. This means that applicants whose claims have been found to be patentable by either the EAPO or KIPO may ask for accelerated examination of their corresponding applications that are pending before the other office.
It will also be possible to request accelerated examination based on a positive written opinion or international preliminary examination report issued by either office acting as the International Searching Authority or the International Preliminary Examining Authority.
The PPH pilot programs will run for an initial term of three years. The term may be extended with a mutual consent of the offices.
For further information please contact Mr Erik Goussev, Patent Attorney.
Also this year we are present at INTA 2019 in Boston and are arranging presentations on IP Trends in Russia and hosting a cocktail reception on Monday 20 May at the Revere Hotel Boston Common.
Read the main impacts on EU trademarks and EU designs, in case the UK leaves EU on 29 March 2019 without a withdrawal agreement.
In the survey taking place for the ninth year, Papula-Nevinpat was ranked in the Silver Category in the prosecution and strategy sector.
The term of a pharmaceutical or plant production patent can be extended by a maximum of 5 years, up to 25 years altogether. Who is entitled and under which conditions? To find out read the blog by our experts Katja Feiring and Erja Partio.
